BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 24670702)

  • 21. Pyrazinamide resistance and mutations in pncA among isolates of Mycobacterium tuberculosis from Khyber Pakhtunkhwa, Pakistan.
    Khan MT; Malik SI; Ali S; Masood N; Nadeem T; Khan AS; Afzal MT
    BMC Infect Dis; 2019 Feb; 19(1):116. PubMed ID: 30728001
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Non-
    Werngren J; Alm E; Mansjö M
    J Clin Microbiol; 2017 Jun; 55(6):1920-1927. PubMed ID: 28404681
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Phenotypic characterization of pyrazinamide-resistant Mycobacterium tuberculosis isolated in Poland].
    Napiórkowska A; Augustynowicz-Kopeć E; Zwolska Z
    Pneumonol Alergol Pol; 2010; 78(4):256-62. PubMed ID: 20665445
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Molecular epidemiological study of pyrazinamide-resistance in clinical isolates of mycobacterium tuberculosis from South India.
    Muthaiah M; Jagadeesan S; Ayalusamy N; Sreenivasan M; Prabhu SS; Muthuraj U; Senthilkumar K; Veerappan S
    Int J Mol Sci; 2010 Jul; 11(7):2670-80. PubMed ID: 20717529
    [TBL] [Abstract][Full Text] [Related]  

  • 25. New mutations in pncA of in vitro selected pyrazinamide-resistant strains of Mycobacterium tuberculosis.
    Bamaga M; Zhang H; Wright DJ
    Microb Drug Resist; 2001; 7(3):223-8. PubMed ID: 11759083
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Phenotypic and genotypic characterization of pyrazinamide resistance among multidrug-resistant Mycobacterium tuberculosis isolates in Zhejiang, China.
    Xia Q; Zhao LL; Li F; Fan YM; Chen YY; Wu BB; Liu ZW; Pan AZ; Zhu M
    Antimicrob Agents Chemother; 2015 Mar; 59(3):1690-5. PubMed ID: 25583712
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fluoroquinolone and pyrazinamide resistance in multidrug-resistant tuberculosis.
    Pierre-Audigier C; Surcouf C; Cadet-Daniel V; Namouchi A; Heng S; Murray A; Guillard B; Gicquel B
    Int J Tuberc Lung Dis; 2012 Feb; 16(2):221-3, i-ii. PubMed ID: 22236923
    [TBL] [Abstract][Full Text] [Related]  

  • 28. pncA mutations as a major mechanism of pyrazinamide resistance in Mycobacterium tuberculosis: spread of a monoresistant strain in Quebec, Canada.
    Cheng SJ; Thibert L; Sanchez T; Heifets L; Zhang Y
    Antimicrob Agents Chemother; 2000 Mar; 44(3):528-32. PubMed ID: 10681313
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Characterization of pncA mutations in multi-drug and pyrazinamide resistant Mycobacterium tuberculosis isolates cultured from Queensland migrants and Papua New Guinea residents.
    Pandey S; Lavu E; Congdon J; Moke R; Bainomugisa A; Coulter C
    Tuberculosis (Edinb); 2018 Jul; 111():109-113. PubMed ID: 30029894
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Prevalence and transmission of pyrazinamide-resistant
    Liu BB; Hu PL; Chen ZH; Yi SL; Zhang XP; Tan YH
    Zhonghua Jie He He Hu Xi Za Zhi; 2022 Jul; 45(7):677-685. PubMed ID: 35768376
    [No Abstract]   [Full Text] [Related]  

  • 31. Development and evaluation of a line probe assay for rapid identification of pncA mutations in pyrazinamide-resistant mycobacterium tuberculosis strains.
    Sekiguchi J; Nakamura T; Miyoshi-Akiyama T; Kirikae F; Kobayashi I; Augustynowicz-Kopec E; Zwolska Z; Morita K; Suetake T; Yoshida H; Kato S; Mori T; Kirikae T
    J Clin Microbiol; 2007 Sep; 45(9):2802-7. PubMed ID: 17596354
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Half of rifampicin-resistant Mycobacterium tuberculosis complex isolated from tuberculosis patients in Sub-Saharan Africa have concomitant resistance to pyrazinamide.
    Ngabonziza JCS; Diallo AB; Tagliani E; Diarra B; Kadanga AE; Togo ACG; Thiam A; de Rijk WB; Alagna R; Houeto S; Ba F; Dagnra AY; Ivan E; Affolabi D; Schwoebel V; Trebucq A; de Jong BC; Rigouts L; Daneau G;
    PLoS One; 2017; 12(10):e0187211. PubMed ID: 29088294
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Multicenter Study of the Emergence and Genetic Characteristics of Pyrazinamide-Resistant Tuberculosis in China.
    Li D; Hu Y; Werngren J; Mansjö M; Zheng X; Drobniewski F; Hoffner S; Xu B
    Antimicrob Agents Chemother; 2016 Sep; 60(9):5159-66. PubMed ID: 27297481
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Phenotypic and genotypic characterization of drug-resistant Mycobacterium tuberculosis strains.
    Clemente WT; Soares Lima SS; Palaci M; Silva MS; Sumnienski Rodrigues VF; Dalla Costa ER; Possuelo L; Cafrune PI; Ribeiro FK; Gomes HM; Serufo JC
    Diagn Microbiol Infect Dis; 2008 Oct; 62(2):199-204. PubMed ID: 18687558
    [TBL] [Abstract][Full Text] [Related]  

  • 35. High prevalence of phenotypic pyrazinamide resistance and its association with pncA gene mutations in Mycobacterium tuberculosis isolates from Uganda.
    Naluyange R; Mboowa G; Komakech K; Semugenze D; Kateete DP; Ssengooba W
    PLoS One; 2020; 15(5):e0232543. PubMed ID: 32413052
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Characterization of pncA mutations in pyrazinamide-resistant Mycobacterium tuberculosis.
    Scorpio A; Lindholm-Levy P; Heifets L; Gilman R; Siddiqi S; Cynamon M; Zhang Y
    Antimicrob Agents Chemother; 1997 Mar; 41(3):540-3. PubMed ID: 9055989
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Characterisation of pncA mutations in clinical Mycobacterium tuberculosis isolates in New Zealand.
    Pandey S; Newton S; Upton A; Roberts S; Drinković D
    Pathology; 2009; 41(6):582-4. PubMed ID: 19900109
    [TBL] [Abstract][Full Text] [Related]  

  • 38. pncA mutations in pyrazinamide-resistant Mycobacterium tuberculosis clinical isolates from the southeast region of Brazil.
    Barco P; Cardoso RF; Hirata RD; Leite CQ; Pandolfi JR; Sato DN; Shikama ML; de Melo FF; Mamizuka EM; Campanerut PA; Hirata MH
    J Antimicrob Chemother; 2006 Nov; 58(5):930-5. PubMed ID: 16971417
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clonal expansion of Mycobacterium tuberculosis isolates and coexisting drug resistance in patients newly diagnosed with pulmonary tuberculosis in Hanoi, Vietnam.
    Hung NV; Ando H; Thuy TT; Kuwahara T; Hang NT; Sakurada S; Thuong PH; Lien LT; Keicho N
    BMC Res Notes; 2013 Nov; 6():444. PubMed ID: 24188178
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Detection of pncA mutation associated with pyrazinamide resistance in Mycobacterium tuberculosis by high-resolution melting cure analysis].
    Hong CY; Wang F; Liu XL
    Zhonghua Jie He He Hu Xi Za Zhi; 2013 Mar; 36(3):198-201. PubMed ID: 23856143
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.